v3.26.1
Stockholders' Equity
 6 Months Ended
Apr. 30, 2026
Stockholders' Equity Note [Abstract]  
Stockholders' Equity
Note 8. Stockholders' Equity
Analysis of Changes in Accumulated Other Comprehensive Loss:
(In millions)Foreign Currency Translation AdjustmentMinimum Pension LiabilityDerivative InstrumentsTotal
Balance at October 31, 2024$(461.7)$(4.9)$44.9 $(421.7)
Gross change in value51.0 — (28.5)22.5 
Tax effect— — 6.9 6.9 
Balance at April 30, 2025$(410.7)$(4.9)$23.3 $(392.3)
Balance at October 31, 2025$(426.2)$1.7 $18.0 $(406.5)
Gross change in value46.9 — (4.8)42.1 
Tax effect— — 1.2 1.2 
Balance at April 30, 2026$(379.3)$1.7 $14.4 $(363.2)
Share Repurchases
In September 2025, the authorization under the 2012 Share Repurchase Program was increased to $2.0 billion by the Company's Board of Directors. As of April 30, 2026, $860.8 million remains authorized for repurchase.
During the three and six months ended April 30, 2026, the Company repurchased 0.2 million and 1.3 million shares of its common stock for $13.1 million and $105.6 million, at a weighted average price of $75.84 and $81.21 per share. During the three and six months ended April 30, 2025, the Company repurchased 0.5 million shares of its common stock for $40.6 million, at a weighted average price of $75.60 per share.